GlassScriptPhysician profile
Joseph R Lee
NPI 1255368460
$15,074.01
in general payments reported to CMS, 2019-2025
21 companies · $1,521 in 2025
The $1,521 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,275 · 2020: $181 · 2021: $893 · 2022: $2,327 · 2023: $5,882 · 2024: $1,995 · 2025: $1,521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,896 · Food and Beverage: $2,502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,896.12 |
| Food and Beverage | $2,502.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,422.19 | 2021-2024 | Resolute Onyx, Onyx Frontier, Symplicity G3 |
| Abbott Laboratories | $2,089.27 | 2019-2025 | Optis, Aveir, Cardiomems |
| Terumo Medical Corporation | $1,610.30 | 2022 | |
| Medtronic Vascular, INC. | $1,459.57 | 2019-2020 | |
| Philips North America LLC | $1,254.77 | 2025 | Coronary Other |
| Abiomed | $363.18 | 2021-2024 | Impella |
| Amgen INC. | $343.29 | 2021-2024 | Repatha |
| Cardiovascular Systems INC. | $220.99 | 2019-2021 | |
| Boston Scientific Corporation | $187.50 | 2019-2025 | Avvigo Guidance System, Emerge Push |
| E.R. Squibb & Sons, L.L.C. | $164.99 | 2019-2024 | Camzyos |
| Heartflow, INC. | $161.18 | 2019-2023 | Ffrct |
| Chiesi USA, INC. | $155.49 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $124.65 | 2019 | |
| Penumbra, INC. | $122.00 | 2024 | Indigo System |
| Pfizer INC. | $119.43 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $104.02 | 2019 | |
| Intuitive Surgical, INC. | $79.03 | 2019 | |
| Edwards Lifesciences Corporation | $34.64 | 2022 | |
| Janssen Pharmaceuticals, INC | $33.00 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $24.52 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.